COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Critical evaluation of the discrepancy between whole and refined foods: nutritional implications
- Concordance of caregivers and nutritionist MUAC measurements for acute malnutrition screening among children in rural Zimbabwe: A comparative study of the FL-MUAC Approach
- Cyclodextrins for UV Protection in Food, Beverages, and Agricultural Products: A Comprehensive Review
- Development of an Edible Film - Lined Tetra Pak: Accelerated Shelf Life of Extra Virgin Olive Oil
- Hepatorenal and Cerebral Toxicity Induced by Consumption of Cow Meat Singed with Scrap Tyres: An Experimental Study in a Rat Model
- Abstract Book: 2nd International Congress on Food Sciences Sustainability, Innovation and Health. 2025
- Modeling of nitrate leaching kinetics during spinach leaf midribs blanching
- Nutritional properties and plausible benefits of Pearl millet (Pennisetum glaucum) on bone metabolism and osteoimmunology : a mini-review
- Rapid survey on lifestyle changes and body weight gain among Algerians during COVID-19 lockdown
- Farm-to-school nutrition programs with special reference to Egypt and Morocco
You may also start an advanced similarity search for this article.
NAJFNR is licensed under